chartexchange

KROS
Keros Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:51 PM EST
12.03USD+6.366%(+0.72)547,252
After-hoursNov 18, 2026 4:26:30 PM EST
12.00USD-0.249%(-0.03)
Loading…
Loading…
235.79M
Healthcare
Biotechnology
HQ
Lexington, MA, USA
Previous Close
$11.31
Beta
1.16
52-Week High
$22.55 2025-12-08
52-Week Low
$8.98 2026-11-10
SMA 50
$11.03
SMA 200
$11.52
Avg. Vol 10D
303,233
Avg. Vol 30D
206,249
Avg. Vol 90D
196,626
Relative Vol
2.65
17.49M
0.7200%
KROS Profile

keros therapeutics, inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. the company's lead protein therapeutic product candidate is ker-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, or mds, and in patients with myelofibrosis. it is also developing small molecule product candidate ker-047 that is being developed for the treatment of anemia, as well as for the treatment of fibrodysplasia ossificans progressiva, or fop, and is currently in a phase 1 clinical trial; and ker-012 being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension, or pah. the company was founded i

KROS Performance
PeriodPriceDateChangeBeta
1W10.082026-11-12+19.20%3.553
1M11.062026-10-19+8.63%1.241
3M11.102026-08-19+8.24%1.327
6M9.912026-05-19+21.24%1.004
1Y16.862025-11-19-28.74%1.159
2Y53.622024-11-19-77.59%—
5Y59.842021-11-19-79.92%1.071
KROS Stock Summary

Keros Therapeutics, Inc. Common Stock (NASDAQ:KROS) stock price today is $12.02, and today's volume is 547,252. KROS is up 6.233% today. The 30 day average volume is 206,249. KROS market cap is $235.79M with 19.62M shares outstanding.